MedTrace Logo

Using Urine Samples to Identify Lung Cancer

NCT06033248 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2025-07-20

No results posted yet for this study

Summary

The researchers are doing this study to test the ability of an animal biosensor platform (ABP) to detect NSCLC. Participants in this study will either be diagnosed with NSCLC, suspected to have NSCLC, or have not been diagnosed or suspected to have NSCLC.

The ABP test uses laboratory animals that are trained to detect (by smell) different chemicals in urine. Studies show that people with lung cancer have unique chemicals in their urine that are not present in people without lung cancer, and researchers think these chemicals can be used to identify people with lung cancer without the need for invasive procedures (like biopsy).

Conditions

  • Non Small Cell Lung Cancer

Interventions

DIAGNOSTIC_TEST

urine sample

urine sample will be collected

Sponsors & Collaborators

Principal Investigators

  • Gaetano Rocco, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-24
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06033248 on ClinicalTrials.gov